| Financial Year |
March 31 2023 |
| Monetary Funds |
134,231,242.29 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
103,448,921.97 |
| Accounts Receivable |
343,864,958.46 |
| Advances to Suppliers |
24,733,621.23 |
| Other Receivables |
1,994,870.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
337,383,570.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,643,241.76 |
| Total Current Assets |
1,091,594,899.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
150,385,973.03 |
| Under-construction Projects |
29,031,720.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,523,790.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
5,916,000.93 |
| Other Non-Current Assets |
43,668,475.42 |
| Sub-Total of Non-Current Assets |
261,525,960.53 |
| Total Assets |
1,353,120,860.02 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,134,585.17 |
| Accounts Payable |
61,857,749.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
7,767,071.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,397,267.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
170,153,469.32 |
| Sub-Total of Current Liabilities |
396,986,034.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,446,974.46 |
| Total Liabilities |
406,433,009.25 |
| Paid-In Capital(Or Share Stock) |
156,000,000.00 |
| Capital Surplus |
368,578,506.66 |
| Surplus Reserve |
43,441,654.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
378,667,689.87 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
946,687,850.77 |
| Owner's Equity（Stockholder's Equity） |
946,687,850.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,353,120,860.02 |
